Barbara Cavalieri

Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injury

Riccardo Bertini, Marcello Allegretti, Cinzia Bizzarri et al. · Proceedings of the National Academy of Sciences · 2004 · 336 citations · Full text

Unique Mode, Immunology, Pharmacotherapy +20

Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2

Federica Casilli, Andrea Bianchini, Isabelle Gloaguen et al. · Biochemical Pharmacology · 2004 · 108 citations

Inflammation, Cytokine, Chemokine Biology +13

The Interleukin-8 (IL-8/CXCL8) Receptor Inhibitor Reparixin Improves Neurological Deficits and Reduces Long-term Inflammation in Permanent and Transient Cerebral Ischemia in Rats

Pia Villa, Sara Triulzi, Barbara Cavalieri et al. · Molecular Medicine · 2007 · 86 citations · Full text

Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non‐competitive allosteric inhibitor

Riccardo Bertini, AR Beccari, Barbara Cavalieri et al. · British Journal of Pharmacology · 2011 · 72 citations · Full text

Reparixin, an Inhibitor of CXCR2 Function, Attenuates Inflammatory Responses and Promotes Recovery of Function after Traumatic Lesion to the Spinal Cord

Alfredo Gorio, Laura Madaschi, Giorgia Zadra et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 58 citations